Oral Sortilin Inhibitor VES001 Safely Raises Progranulin in First Human Trial
A phase 1 randomized trial in 79 healthy adults demonstrates that the oral small-molecule sortilin inhibitor VES001 is well tolerated, ...
A phase 1 randomized trial in 79 healthy adults demonstrates that the oral small-molecule sortilin inhibitor VES001 is well tolerated, ...
A systematic review and meta-analysis of 16 clinical trials found that RIPK1 inhibitors did not increase adverse event risk compared ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.